ArticleNeuro-oncology advances

Phase I trial of convection-enhanced delivery of nimustine hydrochloride (ACNU) for brainstem recurrent glioma.

Ryuta Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.